Livzon Pharmaceutical Secures Exclusive Rights to Onconic’s GERD Treatment Zastaprazan
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced a licensing agreement with South Korean...
China-based Livzon Pharmaceutical Group Inc. (HKG: 1513) has announced a licensing agreement with South Korean...